Drug Type Recombinant polypeptide, Therapeutic vaccine |
Synonyms |
Target |
Mechanism ASTE1 modulators(asteroid homolog 1 modulators), TAF1B modulators(TATA-box binding protein associated factor, RNA polymerase I subunit B modulators), TGFBR2 inhibitors(Transforming growth factor beta receptor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NO | 27 Nov 2023 |